These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5555293)

  • 1. [Influence of therapy on the longevity of patients with plasmacytoma in relation to disease stage and intensity of therapy].
    Fröhlich C; Köhle U; Rietsch R
    Med Welt; 1971 Apr; 17():713-7. PubMed ID: 5555293
    [No Abstract]   [Full Text] [Related]  

  • 2. [Duration of disease and survival time in plasmacytoma].
    Rautenstrauch H
    Z Gesamte Inn Med; 1970 Dec; 25(23):1071-4. PubMed ID: 5512749
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytostatic treatment of plasmacytoma].
    Günther I; Gladitz G
    Z Gesamte Inn Med; 1972 Nov; 27(21):933-7. PubMed ID: 4662918
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of chemotherapy on the survival of patients with generalized plasmacytoma and various hazards of its toxicity].
    Sakalová A; Hrubisko M; Gazová S; Steruská M; Prümmerová J; Oravská D; Pokorná G; Mayer J
    Vnitr Lek; 1979 May; 25(5):425-35. PubMed ID: 452427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prognosis of plasmacytoma].
    Hartwich G
    Lebensversicher Med; 1978 Jan; 30(1):10-4. PubMed ID: 23472
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical outcome of extramedullary plasmacytoma.
    Galieni P; Cavo M; Pulsoni A; Avvisati G; Bigazzi C; Neri S; Caliceti U; Benni M; Ronconi S; Lauria F
    Haematologica; 2000 Jan; 85(1):47-51. PubMed ID: 10629591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total and single doses influence the effectiveness of radiotherapy in palliative treatment of plasmacytoma.
    Stölting T; Knauerhase H; Klautke G; Kundt G; Fietkau R
    Strahlenther Onkol; 2008 Sep; 184(9):465-72. PubMed ID: 19016025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic features of plasmacytomas: a multicenter study of Turkish Oncology Group-Sarcoma Working Party.
    Kilciksiz S; Celik OK; Pak Y; Demiral AN; Pehlivan M; Orhan O; Tokatli F; Agaoglu F; Zincircioglu B; Atasoy BM; Ozseker N; Yersal O; Niang U; Haydaroglu A;
    Am J Hematol; 2008 Sep; 83(9):702-7. PubMed ID: 18543343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localized Plasmacytomas.
    Bataille R
    Clin Haematol; 1982 Feb; 11(1):113-22. PubMed ID: 7042147
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood diseases in the aged, their diagnosis and therapy].
    Waller HD; Benöhr HC; Braun HJ; Castrillon-Oberndorfer W
    Dtsch Med J; 1971 Feb; 22(3):67-71. PubMed ID: 5540728
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the control of the disease course and life expectation in plasmacytoma patients by chemotherapy].
    Gerhartz H; Obrecht P; Ramsbott C
    Verh Dtsch Ges Inn Med; 1965; 71():496-8. PubMed ID: 5877663
    [No Abstract]   [Full Text] [Related]  

  • 12. Solitary plasmacytoma: is radiation therapy sufficient?
    Kumar S
    Am J Hematol; 2008 Sep; 83(9):695-6. PubMed ID: 18645990
    [No Abstract]   [Full Text] [Related]  

  • 13. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
    Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors influencing survival in solitary plasmacytoma.
    Ramsingh G; Mehan P; Morgensztern D; Luo J; Vij R
    Br J Haematol; 2009 May; 145(4):540-2. PubMed ID: 19298587
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous stem cell transplantation in patients with high-risk plasmacytoma.
    Jantunen E; Koivunen E; Putkonen M; Siitonen T; Juvonen E; Nousiainen T
    Eur J Haematol; 2005 May; 74(5):402-6. PubMed ID: 15813914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Should all younger patients with breast cancer be offered adjuvant cytotoxic chemotherapy?].
    Kroman NT; Jensen MB; Wohlfahrt J; Mouridsen H; Andersen PK; Melbye M
    Ugeskr Laeger; 2000 May; 162(22):3184-8. PubMed ID: 10850209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
    Ott OJ; Rödel C; Gramatzki M; Niedobitek G; Sauer R; Grabenbauer GG
    Strahlenther Onkol; 2003 Oct; 179(10):694-701. PubMed ID: 14566478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of paraproteinemic diseases].
    Fölsch E
    Dtsch Med J; 1968 Aug; 19(15):517-22. PubMed ID: 4887941
    [No Abstract]   [Full Text] [Related]  

  • 19. Solitary extramedullary plasmacytoma of the head and neck--long-term outcome analysis of 68 cases.
    Bachar G; Goldstein D; Brown D; Tsang R; Lockwood G; Perez-Ordonez B; Irish J
    Head Neck; 2008 Aug; 30(8):1012-9. PubMed ID: 18327783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's lymphoma in the elderly with special reference to type and intensity of chemotherapy in relation to prognosis.
    Landgren O; Algernon C; Axdorph U; Nilsson B; Wedelin C; Porwit-MacDonald A; Grimfors G; Björkholm M
    Haematologica; 2003 Apr; 88(4):438-44. PubMed ID: 12681971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.